Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1

Cellular Signalling
Xin SongYa Cao

Abstract

Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) is essential for the immortalization of human B cells and is linked etiologically to several human tumors. LMP1 is an integral membrane protein which acts like a constitutively active receptor. It binds tumor necrosis factor (TNF)-receptor-associated factors (TRAFs), activates NFkappaB and triggers the transcription factor activating protein-1 (AP-1) via the c-Jun N-terminal kinase (JNK) cascade, but its specific contribution to AP-1 has not been elucidated fully. Members of AP-1 family, the Jun and fos related protein, have been shown to directly interact and form heterodimeric complexes. In this report, using a Tet-on LMP1 HNE2 cell line which is a dual-stable LMP1 integrated nasopharyngeal carcinoma (NPC) cell line and the expression of LMP1 in which could be regulated by Tet-on system, we show that Jun B can efficiently form a new heterodimeric complex with the c-Jun protein under the regulation of LMP1, phosphorylation of c-Jun (ser63, ser73) and Jun B involved in the process of the new heterodimeric form. We also find that this heterodimeric form can bind to the AP-1 consensus sequence. Transfection studies suggest that JNK interaction protein (JIP) could i...Continue Reading

References

Oct 17, 1991·Nature·B J PulvererJ R Woodgett
Jul 14, 1995·The Journal of Biological Chemistry·M Karin
Jan 1, 1993·Developmental Genetics·K H SchlingensiepenW Brysch
Apr 1, 1997·Current Opinion in Cell Biology·M KarinE Zandi
Apr 1, 1997·The EMBO Journal·E Bossy-WetzelM Yaniv
Jan 24, 1998·The Journal of Biological Chemistry·S Y FuchsZ Ronai
Feb 7, 1998·The Journal of Biological Chemistry·E ChalauxF Ventura
Oct 21, 1998·Oncogene·S Y FuchsZ Ronai
Sep 4, 1999·Circulation Research·N WangM B Stemerman
Dec 2, 1999·Experimental Cell Research·R Wisdom
Feb 15, 2000·The Journal of Biological Chemistry·N R Chapman, N D Perkins
Dec 15, 2000·Plant Physiology·F M Ausubel
Jun 16, 2001·International Journal of Cancer. Journal International Du Cancer·Y DongM Tokuda
Jun 13, 2001·Oncogene·P K Vogt
Dec 1, 2001·The Journal of Biological Chemistry·Sarah M Jacobs-HelberStephen T Sawyer
Feb 28, 2002·Journal of Cancer Research and Clinical Oncology·S FinchT Bowden
May 4, 2002·Nature Cell Biology·Eitan Shaulian, Michael Karin

❮ Previous
Next ❯

Citations

Nov 7, 2008·The Journal of Biological Chemistry·Maria VaysbergOlivia M Martinez
Dec 10, 2009·Future Microbiology·Quoc V TuGeorge L Mendz
May 20, 2011·Auris, Nasus, Larynx·Tomokazu YoshizakiKazuhira Endo
Oct 30, 2004·Toxicologic Pathology·Samuel R BoutinJames G Fox
May 1, 2008·Head & Neck·Josephine ChouDavid M Jablons
Aug 19, 2017·Cancer Metastasis Reviews·Yosuke NakanishiTomokazu Yoshizaki
Apr 11, 2006·The Journal of General Virology·Melanie M Brinkmann, Thomas F Schulz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis